Last reviewed · How we verify
NCT07194122: EDEN-RICAPPS
Poor Outcomes Among Patients Aged 65 and Older Presenting to the Emergency Department(EDEN-RICAPPS Study)
trial in Elderly (People Aged 65 or More) in 141,929 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | Hospital Galdakao-Usansolo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 141,929 |
| Start date | 1 January 2019 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Spain |
Conditions studied
- Elderly (People Aged 65 or More) — all drugs for Elderly (People Aged 65 or More) →
- Vital Signs — all drugs for Vital Signs →
Sponsor
Hospital Galdakao-Usansolo
Who can join
Adults 65 to 120, any sex, with Elderly (People Aged 65 or More) or Vital Signs. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our objective is to create and validate predictive models of poor outcome in people over 65 years of age seen in emergency departments. To this end, models will be developed and validated internally, adapting the reference values of vital signs to this population segment and also taking into account their most frequent reasons for consultation. We will use the EDEN cohort of 18374 patients recruited in one week in 2019 in 40 Spanish hospitals. Subsequently, they will be externally validated in a cohort of 18000 patients prospectively recruited in 7 hospitals in 2024. In addition, the predictive capacity of the FIM frailty scale will be measured. lnformation will be collected from electronic medical records regarding socio-demographic data, functional status, reasons for consultation, clinical and ED history including comorbidities, previous and prescribed ED treatments and vital signs. The main dependent variable is poor outcome defined as ED exitus, admission to ICU/ICU or conventional admission, as well as mortality, revisits and readmissions 30 days after hospital discharge. Updated poor outcome models will be provided that can serve as a basis for creating triage models adapted to the over-65s in the future.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07194122
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Elderly (People Aged 65 or More)
Currently open trials in the same condition.
- NCT07381166 — The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals · NA · recruiting
- NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
- NCT07333989 — Effect of Biofeedback Activation on Balance in Osteoporotic Elderly · NA · recruiting
- NCT07045259 — Effect of Exergaming Program Versus Neuromuscular Exercise in Elderly People With Motor Cognitive Risk Syndrome · NA · recruiting
- NCT07244536 — Effects of Physical Exercise and Cognitive Training on Quality of Life in Elderly Adults · NA · recruiting
Other Hospital Galdakao-Usansolo trials
Trials by the same sponsor.
- NCT07401407 — RICA (ERAS) Pathway Adherence and Early Discharge Feasibility After Urgent Uncomplicated Appendectomy (APENERAS) · completed
- NCT05168722 — COVID-19, Patients' Evolution and the Influence of the Pandemic on Health Care and Outcomes in Chronic Diseases · completed
- NCT05574790 — Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality · completed
- NCT04188990 — Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition · NA · completed
- NCT04463706 — COVID19 Severity Prediction and Health Services Research Evaluation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07194122 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Galdakao-Usansolo
- Last refreshed: 26 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07194122.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing